Abstract
Summary. The present study was aimed at investigation of clinical course of co-existing chronic heart failure (CHF) and COPD and influence of a selective β1-blocker (BB) nebivolol on clinical course of COPD and respiratory function in patients with ischemic CHF. Results showed that a combined therapy of CHF including nebivolol significantly increased effectiveness of CHF treatment irrespective of presence of COPD and did not worsen bronchial obsrtuction. Administration of Nebivolol in patients with coexisting CHF and COPD under the standard therapy did not reduce airflow parameters.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
